Threefer madness: pot stock Tilray eyes hat-trick of gains

Tilray CEO Brendan Kennedy told CNBC that pharmaceutical companies must start thinking about partnering with cannabis producers as a “hedge” against the space.

Read More »

SOURCE: Financial Times

This site is not involved in the creation of this post.

Leave a Reply

Your email address will not be published. Required fields are marked *